Serum GDNF levels and anxiety disorders in a population-based study of young adults

Clinica Chimica Acta - Tập 485 - Trang 21-25 - 2018
Fernanda Pedrotti Moreira1, Carolina David Wiener1,2, Karen Jansen1, Luis Valmor Portela3, Diogo R. Lara4, Luciano Dias de Mattos Souza1, Ricardo Azevedo da Silva1, Jean Pierre Oses1,5
1Translational Science on Brain Disorders, Clinical Neuroscience Laboratory, Department of Health and Behavior, Catholic University of Pelotas, RS, Brazil
2Anhanguera College of Rio Grande, RS, Brazil
3Neurotrauma Laboratory, Department of Biochemistry, Institute of Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
4Neurochemistry and Psychopharmacology Laboratory, Cellular and Molecular Biology Department, Pontifical Catholic University of Rio Grande do Sul (PUC-RS), Porto Alegre, Brazil
5Technology Application in Neurosciences, Department of Electronic Engineering and Computer, Catholic University of Pelotas

Tài liệu tham khảo

Kessler, 2007, Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative, World Psychiatry, 6, 168 Baxter, 2013, Global prevalence of anxiety disorders: a systematic review and meta-regression, Psychol. Med., 43, 897, 10.1017/S003329171200147X Bandelow, 2016, Biological markers for anxiety disorders, OCD and PTSD: a consensus statement. Part II: neurochemistry, neurophysiology and neurocognition, World J. Biol. Psychiatry, 1 Fonzo, 2015, Common and disorder-specific neural responses to emotional faces in generalised anxiety, social anxiety and panic disorders, Br. J. Psychiatry, 206, 206, 10.1192/bjp.bp.114.149880 Walker, 2015, Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis, JAMA Psychiatry, 72, 334, 10.1001/jamapsychiatry.2014.2502 Phillips, 2017, Brain-derived neurotrophic factor, depression, and physical activity: making the Neuroplastic connection, Neural. Plast., 2017, 7260130, 10.1155/2017/7260130 Fernandes, 2015, Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies, BMC Med., 13, 289, 10.1186/s12916-015-0529-7 Moreira, 2015, The met allele of BDNF Val66Met polymorphism is associated with increased BDNF levels in generalized anxiety disorder, Psychiatr. Genet., 25, 201, 10.1097/YPG.0000000000000097 Suliman, 2013, Brain-derived neurotrophic factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis, Front. Integr. Neurosci., 7, 55, 10.3389/fnint.2013.00055 Nitta, 2004, Hydrophobic dipeptide Leu-Ile protects against neuronal death by inducing brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis, J. Neurosci. Res., 78, 250, 10.1002/jnr.20258 Airaksinen, 2002, The GDNF family: signalling, biological functions and therapeutic value, Nat. Rev. Neurosci., 3, 383, 10.1038/nrn812 Naumenko, 2013, Effect of glial cell line-derived neurotrophic factor on behavior and key members of the brain serotonin system in mouse strains genetically predisposed to behavioral disorders, J. Neurosci. Res., 91, 1628, 10.1002/jnr.23286 Cass, 2006, Protection by GDNF and other trophic factors against the dopamine-depleting effects of neurotoxic doses of methamphetamine, Ann. N. Y. Acad. Sci., 1074, 272, 10.1196/annals.1369.024 Diniz, 2012, Circulating Glial-derived neurotrophic factor is reduced in late-life depression, J. Psychiatr. Res., 46, 135, 10.1016/j.jpsychires.2011.09.007 Wang, 2011, Association study between plasma GDNF and cognitive function in late-onset depression, J. Affect. Disord., 132, 418, 10.1016/j.jad.2011.03.043 Rosa, 2006, Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder, Neurosci. Lett., 407, 146, 10.1016/j.neulet.2006.08.026 Fontenelle, 2012, Neurotrophic factors in obsessive-compulsive disorder, Psychiatry Res., 199, 195, 10.1016/j.psychres.2012.03.034 Jockers-Scherubl, 2007, Nerve growth factor serum concentrations rise after successful cognitive-behavioural therapy of generalized anxiety disorder, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 31, 200, 10.1016/j.pnpbp.2006.09.006 Barros, 2005, A nationwide wealth score based on the 2000 Brazilian demographic census, Rev Saúde Pública, 39, 523, 10.1590/S0034-89102005000400002 Buchsbaum, 1992, Screening for drinking disorders in the elderly using the CAGE questionnaire, J. Am. Geriatr. Soc., 40, 662, 10.1111/j.1532-5415.1992.tb01956.x Sheehan, 1998, The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10, J. Clin. Psychiatry, 59 Tunca, 2014, Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: the role of lithium, J. Affect. Disord., 166, 193, 10.1016/j.jad.2014.05.012 de Azevedo, 2014, Neurotrophic factors, clinical features and gender differences in depression, Neurochem. Res., 39, 1571, 10.1007/s11064-014-1349-4 Tunca, 2015, Diverse glial cell line-derived neurotrophic factor (GDNF) support between mania and schizophrenia: a comparative study in four major psychiatric disorders, Euro. Psychiatry, 30, 198, 10.1016/j.eurpsy.2014.11.003 Lin, 2015, Decreased glial cell line-derived neurotrophic factor levels in patients with depression: a meta-analytic study, J. Psychiatr. Res., 63, 20, 10.1016/j.jpsychires.2015.02.004 Barbosa, 2011, Circulating levels of GDNF in bipolar disorder, Neurosci. Lett., 502, 103, 10.1016/j.neulet.2011.07.031 Etkin, 2007, Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia, Am. J. Psychiatry, 164, 1476, 10.1176/appi.ajp.2007.07030504 World Health Organization, 2008